Hi, Thor Medical is a Norwegian company working on alpha-particle therapy for cancer. They extract and produce radioactive isotopes such as Thorium-228, Radium-224, and Lead-212 from ordinary thorium, using a smart and environmentally friendly method that does not require reactors or cyclotrons. It’s called AlphaCycle, and it gives them both lower costs and a more stable supply than their competitors.
They have a pilot plant at Herøya that’s already up and running, and now they’re building their first full-scale commercial plant, called AlphaOne. It is scheduled to be ready for production in 2026, and they already have several long-term agreements with companies that will use the substances in their cancer treatments.
Recent reports show that construction is proceeding according to plan—they reached mechanical completion in April, and they expect to begin full-scale production this fall. They have a healthy cash position, and even though they’re currently operating at a loss (which is completely normal at this stage), it appears they’re well-positioned to scale up. The stock has been a bit volatile, but it’s now trading around 4 kr, and there are several positive milestones on the horizon.
I think this could be a good entry point right now because they are on the verge of the major transition from “construction and development” to actual revenue and commercial operations. Once AlphaOne gets up and running, it opens the door to much larger volumes and potentially significant value creation. The market for this type of precision cancer treatment is growing rapidly, and Thor Medical holds a unique position with its technology.
[https://www.linkedin.com/posts/lead212-radiopharmaceuticals-targetedalphatherapy-share-7470794393537458176-8b2R/?utm\_source=share&utm\_medium=member\_ios&rcm=ACoAADUVyGgBbKFcdpxXInSkiOE2XLD9nnPl2WY](https://www.linkedin.com/posts/lead212-radiopharmaceuticals-targetedalphatherapy-share-7470794393537458176-8b2R/?utm_source=share&utm_medium=member_ios&rcm=ACoAADUVyGgBbKFcdpxXInSkiOE2XLD9nnPl2WY)
